Abstract
Lower doses of mood stabilizers may be necessary in patients receiving Methadone, especially when considering the metabolic syndrome and prolongation of QT interval which both Methadone and some psychoactive medications can cause. Research has shown that Methadone is a µ-opioid receptor agonist, as well as a serotonin and noradrenaline uptake inhibi-tor and NMDA receptor antagonist. Moreover, Methadone has the most evidence of efficacy in comorbid BD and opioid use disorder.We present here a case of a pregnant individual with a history of substance use disorder, BD-II and ADHD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 7-8 |
| Number of pages | 2 |
| Journal | Heroin Addiction and Related Clinical Problems |
| Volume | 22 |
| Issue number | 1 |
| State | Published - Feb 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bipolar disorder
- Methadone
- Opioid Use Disorder
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Mood stabilizing effects of methadone in opioid use disorder patient'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS